

[ Wed, Jul 31st 2024
] - WOPRAI

[ Mon, Jul 15th 2024
] - WOPRAI


[ Fri, Dec 29th 2023
] - WOPRAI


[ Thu, Sep 21st 2023
] - WOPRAI

[ Thu, Jun 15th 2023
] - WOPRAI

[ Mon, Apr 17th 2023
] - WOPRAI

[ Wed, Feb 22nd 2023
] - WOPRAI

[ Thu, Jan 26th 2023
] - WOPRAI

[ Thu, Oct 20th 2022
] - WOPRAI

[ Mon, Oct 17th 2022
] - WOPRAI

[ Fri, Aug 19th 2022
] - WOPRAI

[ Thu, Jul 28th 2022
] - WOPRAI

[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI

[ Wed, Oct 20th 2021
] - WOPRAI


[ Tue, Aug 31st 2021
] - WOPRAI

[ Tue, Jul 20th 2021
] - WOPRAI

[ Wed, Jun 02nd 2021
] - WOPRAI

[ Thu, Jan 28th 2021
] - WOPRAI

[ Tue, Jan 26th 2021
] - WOPRAI

[ Tue, Oct 06th 2020
] - WOPRAI

[ Mon, Jul 06th 2020
] - WOPRAI


[ Mon, Jul 23rd 2018
] - WOPRAI
Marie Thibault Maintained (ATRC) at Strong Buy with Decreased Target to $53 on, Jul 31st, 2024
Marie Thibault of BTIG, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Decreased Target from $58 to $53 on, Jul 31st, 2024.
Marie has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Marie's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Marie
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $49 on, Thursday, May 2nd, 2024
- Suraj Kalia of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $32 on, Tuesday, April 23rd, 2024